Previous work1 demonstrated that epidermal expression of high‐mobility group box 1 (HMGB1) protein is able to discriminate between severe cutaneous adverse drug reactions (ADRs) (SJS/TEN) and maculopapular exanthema. This evidence concerns the gene HMGB1 and exanthem.